Vancouver, British Columbia, October 14, 2025 — TheNewswire - Mydecine Innovations Group Inc. (the “Company”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) is pleased to announce that it has closed the previously announced debt settlement agreements (the “Settlements Agreements”) to settle outstanding debts totaling USD$1,386,391 and CAD$9,432,107 owed to certain arm’s length creditors and a non-arm length creditor (the “Creditors”) of the Company for unpaid invoices, management fees, and unpaid convertible debent ...

 Vancouver, British Columbia, October 6, 2025 — TheNewswire - Mydecine Innovations Group Inc. (the “Company”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) is pleased to announce the results of voting at its annual general and special meeting of shareholders (the “Shareholders”) held on October 1, 2025 (the “Meeting”).At the Meeting, Shareholders approved all resolutions set forth in the Company’s management information circular dated August 20, 2025 (the “Circular”). Disinterested Shareholders also approved all re ...